FEAT DAILY NEWSLETTER
Sacramento, California http://www.feat.org
February 21, 2002
News Archive Search www.feat.org/search/news.asp
·
Promising Strides In Brain Cell Regeneration Research
·
IOM Report On Child Vaccinations Urges More Research
·
Autism Research Group Funds New Website: Genetics of
Autism
·
Interleukin-2 and -6 Induce Behavioral-Activating Effects
In Mice.
·
Reader’s Ads
[By Lee Bowman, Scripps Howard News Service.]
http://nandotimes.com/healthscience/v-text/story/257819p-2411542c.html
Scientists may be moving closer to the day when
neurologists can say “brain, heal thyself.”
Until recently, experts were sure that new brain cells
were impossible for adults to come by, that all the gray matter we get is pretty
much in place well before we reach adolescence.
But there’s new evidence that a few regions of the brain
keep churning out new cells, and new hope that the precursors of those
specialized cells can be coaxed into producing other types of brain cells
needed to reverse or repair damaged regions.
Research on two tracks in rats was reported Monday during
the annual meeting of the American Association for the Advancement of Science.
Dr. Jack Parent, an assistant professor of neurology at the
University of Michigan Medical School, described experiments in which rats
responded to injury from epileptic seizures or strokes by sending primitive
neural cells into those areas and attempting to form new neurons.
The cells are called neuroblasts, about midway in
development between a stem cell and a fully developed neuron.
“What’s fascinating is that neuroblasts responded
similarly to both types of brain injury,” Parent said. “There’s some cue in
common that activates their development and growth. We don’t know what it is,
but we’re looking for growth factors that stimulate the proliferation and
migration of precursor cells.”
Dr. Fred Gage, of the Salk Institute at the University of California-San
Diego, has shown in culture dishes that precursor cells native to regions of
the adult brain that normally generate only glial cells (“housekeeping” cells
that provide support and nutrition to actual nerve cells) can also generate
neurons after being exposed to a growth factor called FGF-2.
Gage and his colleagues have found cells that are
responsive to the growth factor in “widely divergent tissues of the adult
brain,” including the hippocampus, the neocortex and the optic nerve.
Gage’s team also has observed that environmental
enrichment, such as increased social interaction, larger housing, increased
learning opportunities or enhanced exercise, are all able to stimulate
development of new precursor cells in the dentate gyrus, a small area in the memory-generating
part of the brain, in adult rodents.
Still another research group, led by Ronald Duman, a
professor of psychiatry and pharmacology at the Abraham Ribicoff Research
Facilities at Yale University in New Haven, Conn., reported that administration
of an anti-depressant enhances neurogenesis in the adult rodent hippocampus.
Duman said that while more studies are needed to
understand the significance of the process, the findings could offer new
avenues to identify and treat stress-related mood disorders.
Parent is quick to point out, though, that repairing
damaged brain tissue isn’t as simple as swapping out a bad circuit board in a
computer, and that much more work must be done before tests can be conducted on
humans who have sustained brain injuries.
“It’s not enough to stimulate the development of
neuroblasts in human brains and hope they do what you want them to,” he said. “There
can be harmful consequences.”
His team found, for instance, that some of the new cells
do migrate and alter themselves to just the right spot after an injury and differentiate
themselves into the right kind of cell.
But in other instances, after prolonged seizures, the
neuroblasts from the dentate gyrus go where they don’t belong, although they
assume the right shape. “They appear to be abnormally hyper-excitable and wire
into existing nerve cell networks in a way that may lead to seizures.
“So making more new neurons after an injury is not always
a good thing for brain function,” Parent said.
* * *
[From a news announcement from the National Vaccine
Information
Center.]
Washington, D.C. – Responding to a report issued today by
the National Academy of Sciences Institute of Medicine (IOM) on child
vaccinations and autoimmune dysfunction, the nation’s oldest and largest
vaccine safety and informed consent advocacy organization, the National Vaccine
Information Center (NVIC) endorsed IOM’s call for expanded basic science
research into the development of the human immune system and identification of
genetic and other biomarkers which could predispose some children to vaccine
based adverse events, including autoimmunity.
The report, issued by the IOM’s Immunization Safety Review Committee,
found that scientific evidence from epidemiological studies on whether allergy,
including asthma, can be caused by multiple vaccinations was conflicting and
concluded that the evidence “was inadequate to accept or reject a causal
relationship.” The Committee concluded that epidemiological studies to date
“favor rejection of a causal relationship between multiple immunizations and
increased risk for infections and for type 1 diabetes.” However, the Committee
also concluded that they did find some biological mechanism evidence that
vaccines could increase the risk of immune dysfunction in some children that
could lead to increased infections and allergy, including asthma. They stated
that “the biological mechanisms evidence regarding increased risk for
infections is strong.”
The National Vaccine Information Center (NVIC) has long
advocated increased basic science research into the biological mechanisms for
immunity and vaccine adverse events, with particular emphasis on identifying
genetic and other biomarkers that may play a role in increasing susceptibility
for vaccine-induced neuroimmune dysfunction. Acknowledging the absence of research
into this area, the Committee said, “The Committee was unable to address the
concern that repeated exposure of a susceptible child to multiple immunizations
over the developmental period may also produce atypical or non-specific immune
or nervous system injury that could lead to severe disability or death. (Fisher, 2001). There are no epidemiological
studies that address this. Thus, the committee recognizes with some discomfort
that this report addresses only part of the overall set of concerns of some of
those most wary about the safety of childhood immunizations.”
NVIC President Barbara Loe Fisher called the report “an
important step in acknowledging the very real basic science research needs of
our nation’s mass vaccination system. We cannot continue to turn a blind eye to
the growing minority of children who, for biological reasons, are not able to handle
the increasing numbers of vaccinations routinely being given to all children.”
The IOM Committee pointed out that “as the array of
available vaccines and disease targets expands the current emphasis on
universal recommendations and state mandates for vaccine use should be
reassessed.” It encouraged “an exploration of the merits of accomodating
requests for alternative vaccine-dosing schedules and the development of
appropriate clinical guidance for any such alternatives. A more flexible
schedule might allow for a reduction in the number of vaccines administered at
one time.”
Although the IOM Committee report did not recommend a
policy review by the Centers for Disease Control, the Food and Drug
Administration or the American Academy of Pediatrics at this time, the
Committee report summary clearly recommended continued scientific research and
consideration of “new frameworks for immunization policy, particularly as the
number of licensed vaccines increases.”
“While we disagree with some of the Committees conclusions
regarding the relative strengths and weakness of both the epidemiological and biological
mechanism data that bears on proof of causality involved in vaccine-related
autoimmunity and believe that specialized, methodologically sound studies of
possible associations between multiple vaccinations and immune system
dysfunction should be given a high funding and program priority by federal
health agencies, we are pleased that this IOM report has identified a number of
areas in which vaccine adverse event and policy research should be
re-examined,” said Fisher. “We hope that both government and industry will pay
attention to the signals given in this report and work with parents of vaccine
injured children to come to a better scientific understanding of why, for some
children, the risks of vaccination are 100 percent.”
A non-profit, educational organization founded in 1982
by parents of
vaccine injured children, NVIC serves as a consumer watchdog
on vaccine
development and policymaking. NVIC advocates the institution
of safety and
informed consent protections in the mass vaccination system
and basic
science research into genetic and other biological factors
which place some
individuals at high risk for vaccine injury and death. To view the full
report: http://National-Academies.org and www.iom.edu/imsafety
>> DO SOMETHING ABOUT AUTISM NOW <<
Subscribe, Read, then Forward the FEAT Daily
Newsletter.
To Subscribe go to www.feat.org/FEATnews
No Cost!
* * *
Autism Research Group Funds New Website on the Genetics of
Autism
National Alliance for Autism Research Helps Duke & Tufts
Launch
[From an organization announcement.]
Princeton, NJ – A new web-based genetics education tool
for parents and family members of individuals with autism that was funded by
the National Alliance for Autism Research (NAAR) has recently been unveiled to the
general public.
The website, www.exploringautism.org, is designed to
promote genomic literacy among families with a history of autism spectrum
disorders so they better understand the genetic components of autism, the
latest genetic research advances and the potential implications of those
advances. The website is dedicated to helping families who are living with the
challenges of autism stay informed about breakthroughs involving the genetics
of autism. Coordinated by the Center
for Human Genetics at Duke University Medical Center in Durham, N.C. and Tufts
University/New England Medical Center in Boston, MA, the website is the first
project of its kind funded by NAAR.
“This new website is truly a unique resource providing
accurate and easy to understand information that explains the latest
information on autism spectrum disorders, genetic research findings in autism
and genetic principles as they relate to autism spectrum disorders,” said Andy
Shih, Ph.D., director of Research & Programs at NAAR.
The website’s architecture allows visitors users to
navigate the site easily and locate useful information, read current news on
autism-related genetics and take part in an online survey designed to help
researchers evaluate the genetic educational needs of families and other people
who visit the site.
“There is not just data at this website, but useable
information that benefit both family members of people with autism and
healthcare professionals looking for the latest, most accurate information on
the genetics of autism,” said Dr. Shih.
The website is organized by the following key sections:
What is Autism – Provides an overall description of the
autism spectrum disorders, including diagnosis information and genetic
conditions associated with autism.
Genetics Overview – Features a glossary of terms used in
genetics and an explanation of tools used to help researchers locate
susceptibility genes and information on recent investigations on certain
chromosomes.
History of Autism – Includes a timeline of important
advances in autism diagnosis and autism research as well as genetics.
Autism & Environmental Factors – Explores the theory
of complex inheritance and the possible relationship between the environment
and autism spectrum disorders.
Family Stories – Shares the story of the Flores family, of
Raleigh, N.C., which has two children with autism.
Frequently Asked Questions – Lists questions and answers
on autism and inheritance, what genes are involved in autism spectrum
disorders, and ongoing genetic autism studies.
Survey – Online survey open to all users that is being
used to help the Autism Genetics Collaborative determine the educational needs
of families and develop additional educational materials.
NAAR funded the website through a $41,912 grant in awarded
in 2001 to Margaret A. Pericak-Vance, Ph.D., Center for Human Genetics at Duke University
Medical Center; and Susan Folstein, M.D, Department of Psychiatry, Tufts
University/New England Medical University.
Dr. Pericak-Vance and Dr.
Folstein serve as editors of the website, along with Beth Rosen-Sheidley, M.S.,
CGC, New England Medical Center; and Chantelle Wolpert, MBA, PA-C, Duke
University Medical Center. Information on the website is evaluated by the
Autism Genetics Cooperative, an advisory board made up of researchers from
major universities and medical centers.
“We are excited to see this collaborative educational
initiative come to life on the Internet, and feel we are helping to provide a
dynamic, new resource for families and healthcare professionals,” said Prisca
Chen Marvin, Esq., president of NAAR’s Board of Trustees.
* * *
Interleukin-2 and -6 Induce Behavioral-Activating Effects
In Mice.
Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM.
The Manitoba Institute of Cell Biology, University of
Manitoba, 770
Bannatyne Ave., Winnipeg, Mb., Canada. rosellic@ohsu.edu
Interleukin (IL)-1, IL-2 and IL-6 influence central
monoamine activity in a cytokine-specific manner. We demonstrated that whereas
IL-2 increased hypothalamic and hippocampal norepinephrine (NE) utilization,
and DA turnover in the prefrontal cortex, IL-6 induced profound elevations of serotonin
(5-HT) and mesocortical dopamine (DA) activity in the hippocampus and
prefrontal cortex [S. Zalcman, J.M. Green-Johnson, L. Murray, D.M. Nance, D.G. Dyck, H. Anisman, A. H.
Greenberg, Cytokine-specific central monoamine alterations following IL-1, -2
and -6 administration, Brain Res. 643
(1994) 40-49]. IL-1, in contrast, induced a wide range of central monoamine
alterations.
We presently report that these cytokines also
differentially influence behavior. Profound reductions in non-ambulatory and
ambulatory exploration were induced in BALB/c mice following IL-1
administration. In contrast, IL-2-treated mice displayed significant increases
in the time spent engaged in non-ambulatory exploration, digging, rearing
(particularly the number of free rears), and in the investigation of a novel
stimulus (i.e., increased number and duration of stimulus contacts).
IL-6-treated mice, moreover, exhibited significant increases
in the time spent engaged in ambulatory exploration, digging and rearing (particularly
the number of free rears, which tended to be of short duration). Modest
increases in locomotion and grooming were also observed in IL-6-treated
animals. Plasma corticosterone levels did not vary significantly as a function
of IL-6 treatment. Hence, cytokine-specific behavioral-activating effects were
induced following administration of IL-2 and IL-6.
We suggest that these effects have adaptive significance
and relevance to sickness behavior; however, pathological outcomes (e.g.,
schizophrenia, anxious-like states, anxious depression, motor abnormalities)
could develop should these cytokines be overproduced or dysregulated. Copyright
1998 Elsevier Science B.V.
PMID: 9804916 [PubMed - indexed for MEDLINE]
* * *
I Can Too Learning Center is
located in Encinitas, CA and provides intensive, in-home Applied Behavior
Analysis programs for children with autism between 2-7 years of age. Visit us
at www.icantoolc.com
for further information and email us at icantoo@icantoolc for a Parent Information packet.
Been doing ABA for my son(9yrs) with autism who has average IQ for more
than a year. don’t understand why the language improvement
is so slow
compare to other skills ( bike, swim etc ) with the therapy.
He is
verbal(lots of vocabulary), two or three words average.
Sometimes, he tries
to make a longer sentence but the structure is messed up.
Need advice
Live in Southern California, have a 5 ½ year old high
functioning autistic son, and I am interested in finding out more about
chelating therapy, and if there is any physician in Southern California
providing this service.
Anyone have any input on this
therapy, good or bad? elizek@attglobal.net
Unraveling the Mystery of Autism
and PDD - A Mother’s Story of Research and Recovery, by Karyn Seroussi, is now
available in paperback from Broadway Books (a subsidiary of Random House). List
price is $12.95.
Seeking info re after-school program in the Inland Empire
area of Southern
California for my five year old son with autism. Prefer
program that
includes typically developing peers, an environment he has
been successfulin
for the past three year. vahahn@scwater.com
Would like to thank everybody who took the time to email me
in my search for
a puppy for my boy, I now have two!! My son is really happy,
and laughing at
them all the time, they’re his friends as he tells everyone,
and they are.
if anybody out there is considering a dog as a friend for their autistic
child and are having doubts, then don’t because there is no
drug that any
doctor could prescribe, that could make your child feel like
mine does now.
thanks to all for your support
sandra russell
Center for Developmental Excellence ... where no child is
left behind.
Serving New Jersey and Pennsylvania, Interactive Metronome, Sensory
Integration, Therapy Handwriting without Tears, Occupational
Therapy, Brett
S Hann CDEINFO@COMCAST.NET
856-778-1653
Looking for ABA trainer for my 3
y.o. son in Berkley, Michigan. Training provided. Please respond to
sharlan17home.com !
Our 9 y.o. son’s CDSA and microbial OAT tests revealed
that he has very scant amounts of good bacteria in his gut which indicates that
Cuturelle and Pro-Bio Gold from Kirkman that he has been taking for almost a
year is not working. Can anyone advise
us on which probiotic was effectively used?
Also, we need a really good reading comprehension teaching
method or
therapy. Although he
reads at a 5th grade level, he has very poor
comprehension. SChong6@hotmail.com
Does anyone have any info about service dogs for people
(kids) with autism?I
live in Minnesota.
Any info about where to get them, how to train them, and
what they can do for someone
would be great. kisalou@earthlink.net
>>
FREE (Almost) READER’S POSTS <<
For Individuals, organizations, non-commercial and commercial.
Limit your posting to no more than 60 words please. There is no charge for this
service, but posters are obligated to thank all those who take the time to
answer your ads. This is a consideration for others with autism after you and
yours, who seek assistance from appreciated readers. Send submissions to:
APRIL 21, 2002 - 12 Noon to 5pm
“The Power of ONE! I.D.E.A.”
Lenny Schafer, Editor@feat.org • CALENDAR EVENTS@feat.org
Michelle Guppy
Catherine Johnson PhD
• Ron Sleith •
Kay Stammers • Edward Decelie
UNSUBSCRIBE: FEATNews-signoff-request@LIST.FEAT.ORG
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.